UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 83 filers reported holding UROGEN PHARMA LTD in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,218 | +33.6% | 21,823 | 0.0% | 0.07% | +39.6% |
| Q2 2023 | $235,143 | +28.6% | 21,823 | 0.0% | 0.05% | +14.3% |
| Q1 2023 | $182,877 | -0.1% | 21,823 | 0.0% | 0.04% | -2.3% |
| Q4 2022 | $183,010 | +2.2% | 21,823 | 0.0% | 0.04% | +4.9% |
| Q3 2022 | $179,000 | +1.1% | 21,823 | 0.0% | 0.04% | +5.1% |
| Q2 2022 | $177,000 | -6.3% | 21,823 | 0.0% | 0.04% | +18.2% |
| Q1 2022 | $189,000 | -9.1% | 21,823 | 0.0% | 0.03% | -2.9% |
| Q4 2021 | $208,000 | -43.3% | 21,823 | 0.0% | 0.03% | -49.3% |
| Q3 2021 | $367,000 | +10.2% | 21,823 | 0.0% | 0.07% | +13.6% |
| Q2 2021 | $333,000 | -21.6% | 21,823 | 0.0% | 0.06% | -33.0% |
| Q1 2021 | $425,000 | +8.1% | 21,823 | 0.0% | 0.09% | +1.1% |
| Q4 2020 | $393,000 | – | 21,823 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |